N,N-dimethyl-1-(2-methylpropyl)azetidine-3-carboxamide;2,2-dimethyl-4-[1-(2-methylpropyl)azetidin-3-yl]morpholine;(3-hydroxyazetidin-1-yl)-[1-(2-methylpropyl)azetidin-3-yl]methanone;(3-hydroxypyrrolidin-1-yl)-[1-(2-methylpropyl)azetidin-3-yl]methanone;2-methyl-2-[methyl-[1-(2-methylpropyl)azetidin-3-yl]amino]propanamide;bis(7-methyl-2-(2-methylpropyl)-2,7-diazaspiro[3.5]nonan-6-one);N-methyl-1-(2-methylpropyl)-N-(oxetan-3-yl)azetidin-3-amine;2-(2-methylpropyl)-5-oxa-2,8-diazaspiro[3.5]nonan-7-one;1-(2-methylpropyl)-4-(2,2,2-trifluoroethyl)piperazine;N,N,3-trimethyl-1-(2-methylpropyl)azetidine-3-carboxamide;trimethyl-[1-(2-methylpropyl)piperidin-4-yl]azanium

C136H265F3N25O13+ — CID 158227845

IUPACN,N-dimethyl-1-(2-methylpropyl)azetidine-3-carboxamide;2,2-dimethyl-4-[1-(2-methylpropyl)azetidin-3-yl]morpholine;(3-hydroxyazetidin-1-yl)-[1-(2-methylpropyl)azetidin-3-yl]methanone;(3-hydroxypyrrolidin-1-yl)-[1-(2-methylpropyl)azetidin-3-yl]methanone;2-methyl-2-[methyl-[1-(2-methylpropyl)azetidin-3-yl]amino]propanamide;bis(7-methyl-2-(2-methylpropyl)-2,7-diazaspiro[3.5]nonan-6-one);N-methyl-1-(2-methylpropyl)-N-(oxetan-3-yl)azetidin-3-amine;2-(2-methylpropyl)-5-oxa-2,8-diazaspiro[3.5]nonan-7-one;1-(2-methylpropyl)-4-(2,2,2-trifluoroethyl)piperazine;N,N,3-trimethyl-1-(2-methylpropyl)azetidine-3-carboxamide;trimethyl-[1-(2-methylpropyl)piperidin-4-yl]azanium
SMILESCC(C)CN1CC(C(=O)N(C)C)C1.CC(C)CN1CC(C(=O)N2CC(O)C2)C1.CC(C)CN1CC(C(=O)N2CCC(O)C2)C1.CC(C)CN1CC(C)(C(=O)N(C)C)C1.CC(C)CN1CC(N(C)C(C)(C)C(N)=O)C1.CC(C)CN1CC(N(C)C2COC2)C1.CC(C)CN1CC(N2CCOC(C)(C)C2)C1.CC(C)CN1CC2(CCN(C)C(=O)C2)C1.CC(C)CN1CC2(CCN(C)C(=O)C2)C1.CC(C)CN1CC2(CNC(=O)CO2)C1.CC(C)CN1CCC([N+](C)(C)C)CC1.CC(C)CN1CCN(CC(F)(F)F)CC1
InChIInChI=1S/C13H26N2O.C12H25N3O.C12H22N2O2.2C12H22N2O.C12H27N2.C11H20N2O2.2C11H22N2O.C10H19F3N2.C10H18N2O2.C10H20N2O/c1-11(2)7-14-8-12(9-14)15-5-6-16-13(3,4)10-15;1-9(2)6-15-7-10(8-15)14(5)12(3,4)11(13)16;1-9(2)5-13-6-10(7-13)12(16)14-4-3-11(15)8-14;2*1-10(2)7-14-8-12(9-14)4-5-13(3)11(15)6-12;1-11(2)10-13-8-6-12(7-9-13)14(3,4)5;1-8(2)3-12-4-9(5-12)11(15)13-6-10(14)7-13;1-9(2)4-13-5-10(6-13)12(3)11-7-14-8-11;1-9(2)6-13-7-11(3,8-13)10(14)12(4)5;1-9(2)7-14-3-5-15(6-4-14)8-10(11,12)13;1-8(2)3-12-6-10(7-12)5-11-9(13)4-14-10;1-8(2)5-12-6-9(7-12)10(13)11(3)4/h11-12H,5-10H2,1-4H3;9-10H,6-8H2,1-5H3,(H2,13,16);9-11,15H,3-8H2,1-2H3;2*10H,4-9H2,1-3H3;11-12H,6-10H2,1-5H3;8-10,14H,3-7H2,1-2H3;9-11H,4-8H2,1-3H3;9H,6-8H2,1-5H3;9H,3-8H2,1-2H3;8H,3-7H2,1-2H3,(H,11,13);8-9H,5-7H2,1-4H3/q;;;;;+1;;;;;;
InChIKeyYKYTVIMHKAFFLD-UHFFFAOYSA-N
MW2515.77 g/mol
LogP10.15
Rot. Bonds36

About N,N-dimethyl-1-(2-methylpropyl)azetidine-3-carboxamide;2,2-dimethyl-4-[1-(2-methylpropyl)azetidin-3-yl]morpholine;(3-hydroxyazetidin-1-yl)-[1-(2-methylpropyl)azetidin-3-yl]methanone;(3-hydroxypyrrolidin-1-yl)-[1-(2-methylpropyl)azetidin-3-yl]methanone;2-methyl-2-[methyl-[1-(2-methylpropyl)azetidin-3-yl]amino]propanamide;bis(7-methyl-2-(2-methylpropyl)-2,7-diazaspiro[3.5]nonan-6-one);N-methyl-1-(2-methylpropyl)-N-(oxetan-3-yl)azetidin-3-amine;2-(2-methylpropyl)-5-oxa-2,8-diazaspiro[3.5]nonan-7-one;1-(2-methylpropyl)-4-(2,2,2-trifluoroethyl)piperazine;N,N,3-trimethyl-1-(2-methylpropyl)azetidine-3-carboxamide;trimethyl-[1-(2-methylpropyl)piperidin-4-yl]azanium

N,N-dimethyl-1-(2-methylpropyl)azetidine-3-carboxamide;2,2-dimethyl-4-[1-(2-methylpropyl)azetidin-3-yl]morpholine;(3-hydroxyazetidin-1-yl)-[1-(2-methylpropyl)azetidin-3-yl]methanone;(3-hydroxypyrrolidin-1-yl)-[1-(2-methylpropyl)azetidin-3-yl]methanone;2-methyl-2-[methyl-[1-(2-methylpropyl)azetidin-3-yl]amino]propanamide;bis(7-methyl-2-(2-methylpropyl)-2,7-diazaspiro[3.5]nonan-6-one);N-methyl-1-(2-methylpropyl)-N-(oxetan-3-yl)azetidin-3-amine;2-(2-methylpropyl)-5-oxa-2,8-diazaspiro[3.5]nonan-7-one;1-(2-methylpropyl)-4-(2,2,2-trifluoroethyl)piperazine;N,N,3-trimethyl-1-(2-methylpropyl)azetidine-3-carboxamide;trimethyl-[1-(2-methylpropyl)piperidin-4-yl]azanium (PubChem CID 158227845) has the molecular formula C136H265F3N25O13+ and a molecular weight of 2515.77 g/mol. Its IUPAC name is N,N-dimethyl-1-(2-methylpropyl)azetidine-3-carboxamide;2,2-dimethyl-4-[1-(2-methylpropyl)azetidin-3-yl]morpholine;(3-hydroxyazetidin-1-yl)-[1-(2-methylpropyl)azetidin-3-yl]methanone;(3-hydroxypyrrolidin-1-yl)-[1-(2-methylpropyl)azetidin-3-yl]methanone;2-methyl-2-[methyl-[1-(2-methylpropyl)azetidin-3-yl]amino]propanamide;bis(7-methyl-2-(2-methylpropyl)-2,7-diazaspiro[3.5]nonan-6-one);N-methyl-1-(2-methylpropyl)-N-(oxetan-3-yl)azetidin-3-amine;2-(2-methylpropyl)-5-oxa-2,8-diazaspiro[3.5]nonan-7-one;1-(2-methylpropyl)-4-(2,2,2-trifluoroethyl)piperazine;N,N,3-trimethyl-1-(2-methylpropyl)azetidine-3-carboxamide;trimethyl-[1-(2-methylpropyl)piperidin-4-yl]azanium.

Molecular Properties

Compound NameN,N-dimethyl-1-(2-methylpropyl)azetidine-3-carboxamide;2,2-dimethyl-4-[1-(2-methylpropyl)azetidin-3-yl]morpholine;(3-hydroxyazetidin-1-yl)-[1-(2-methylpropyl)azetidin-3-yl]methanone;(3-hydroxypyrrolidin-1-yl)-[1-(2-methylpropyl)azetidin-3-yl]methanone;2-methyl-2-[methyl-[1-(2-methylpropyl)azetidin-3-yl]amino]propanamide;bis(7-methyl-2-(2-methylpropyl)-2,7-diazaspiro[3.5]nonan-6-one);N-methyl-1-(2-methylpropyl)-N-(oxetan-3-yl)azetidin-3-amine;2-(2-methylpropyl)-5-oxa-2,8-diazaspiro[3.5]nonan-7-one;1-(2-methylpropyl)-4-(2,2,2-trifluoroethyl)piperazine;N,N,3-trimethyl-1-(2-methylpropyl)azetidine-3-carboxamide;trimethyl-[1-(2-methylpropyl)piperidin-4-yl]azanium
PubChem CID158227845
Molecular FormulaC136H265F3N25O13+
Molecular Weight2515.77 g/mol
Exact Mass2514.08
IUPAC NameN,N-dimethyl-1-(2-methylpropyl)azetidine-3-carboxamide;2,2-dimethyl-4-[1-(2-methylpropyl)azetidin-3-yl]morpholine;(3-hydroxyazetidin-1-yl)-[1-(2-methylpropyl)azetidin-3-yl]methanone;(3-hydroxypyrrolidin-1-yl)-[1-(2-methylpropyl)azetidin-3-yl]methanone;2-methyl-2-[methyl-[1-(2-methylpropyl)azetidin-3-yl]amino]propanamide;bis(7-methyl-2-(2-methylpropyl)-2,7-diazaspiro[3.5]nonan-6-one);N-methyl-1-(2-methylpropyl)-N-(oxetan-3-yl)azetidin-3-amine;2-(2-methylpropyl)-5-oxa-2,8-diazaspiro[3.5]nonan-7-one;1-(2-methylpropyl)-4-(2,2,2-trifluoroethyl)piperazine;N,N,3-trimethyl-1-(2-methylpropyl)azetidine-3-carboxamide;trimethyl-[1-(2-methylpropyl)piperidin-4-yl]azanium
SMILESCC(C)CN1CC(C(=O)N(C)C)C1.CC(C)CN1CC(C(=O)N2CC(O)C2)C1.CC(C)CN1CC(C(=O)N2CCC(O)C2)C1.CC(C)CN1CC(C)(C(=O)N(C)C)C1.CC(C)CN1CC(N(C)C(C)(C)C(N)=O)C1.CC(C)CN1CC(N(C)C2COC2)C1.CC(C)CN1CC(N2CCOC(C)(C)C2)C1.CC(C)CN1CC2(CCN(C)C(=O)C2)C1.CC(C)CN1CC2(CCN(C)C(=O)C2)C1.CC(C)CN1CC2(CNC(=O)CO2)C1.CC(C)CN1CCC([N+](C)(C)C)CC1.CC(C)CN1CCN(CC(F)(F)F)CC1
InChIInChI=1S/C13H26N2O.C12H25N3O.C12H22N2O2.2C12H22N2O.C12H27N2.C11H20N2O2.2C11H22N2O.C10H19F3N2.C10H18N2O2.C10H20N2O/c1-11(2)7-14-8-12(9-14)15-5-6-16-13(3,4)10-15;1-9(2)6-15-7-10(8-15)14(5)12(3,4)11(13)16;1-9(2)5-13-6-10(7-13)12(16)14-4-3-11(15)8-14;2*1-10(2)7-14-8-12(9-14)4-5-13(3)11(15)6-12;1-11(2)10-13-8-6-12(7-9-13)14(3,4)5;1-8(2)3-12-4-9(5-12)11(15)13-6-10(14)7-13;1-9(2)4-13-5-10(6-13)12(3)11-7-14-8-11;1-9(2)6-13-7-11(3,8-13)10(14)12(4)5;1-9(2)7-14-3-5-15(6-4-14)8-10(11,12)13;1-8(2)3-12-6-10(7-12)5-11-9(13)4-14-10;1-8(2)5-12-6-9(7-12)10(13)11(3)4/h11-12H,5-10H2,1-4H3;9-10H,6-8H2,1-5H3,(H2,13,16);9-11,15H,3-8H2,1-2H3;2*10H,4-9H2,1-3H3;11-12H,6-10H2,1-5H3;8-10,14H,3-7H2,1-2H3;9-11H,4-8H2,1-3H3;9H,6-8H2,1-5H3;9H,3-8H2,1-2H3;8H,3-7H2,1-2H3,(H,11,13);8-9H,5-7H2,1-4H3/q;;;;;+1;;;;;;
InChIKeyYKYTVIMHKAFFLD-UHFFFAOYSA-N
XLogP10.15
TPSA314.04 Ų
H-Bond Donors4
H-Bond Acceptors29
Rotatable Bonds36
Heavy Atoms177
Complexity—

Lipinski Rule of Five

3 violations

RuleValue
MW ≤ 5002515.77
LogP ≤ 510.15
H-Bond Donors ≤ 54
H-Bond Acceptors ≤ 1029

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'quaternary_nitrogen_2', 'substructure': 'N/A'}

Analyze N,N-dimethyl-1-(2-methylpropyl)azetidine-3-carboxamide;2,2-dimethyl-4-[1-(2-methylpropyl)azetidin-3-yl]morpholine;(3-hydroxyazetidin-1-yl)-[1-(2-methylpropyl)azetidin-3-yl]methanone;(3-hydroxypyrrolidin-1-yl)-[1-(2-methylpropyl)azetidin-3-yl]methanone;2-methyl-2-[methyl-[1-(2-methylpropyl)azetidin-3-yl]amino]propanamide;bis(7-methyl-2-(2-methylpropyl)-2,7-diazaspiro[3.5]nonan-6-one);N-methyl-1-(2-methylpropyl)-N-(oxetan-3-yl)azetidin-3-amine;2-(2-methylpropyl)-5-oxa-2,8-diazaspiro[3.5]nonan-7-one;1-(2-methylpropyl)-4-(2,2,2-trifluoroethyl)piperazine;N,N,3-trimethyl-1-(2-methylpropyl)azetidine-3-carboxamide;trimethyl-[1-(2-methylpropyl)piperidin-4-yl]azanium with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Frequently Asked Questions

What is the IUPAC name of N,N-dimethyl-1-(2-methylpropyl)azetidine-3-carboxamide;2,2-dimethyl-4-[1-(2-methylpropyl)azetidin-3-yl]morpholine;(3-hydroxyazetidin-1-yl)-[1-(2-methylpropyl)azetidin-3-yl]methanone;(3-hydroxypyrrolidin-1-yl)-[1-(2-methylpropyl)azetidin-3-yl]methanone;2-methyl-2-[methyl-[1-(2-methylpropyl)azetidin-3-yl]amino]propanamide;bis(7-methyl-2-(2-methylpropyl)-2,7-diazaspiro[3.5]nonan-6-one);N-methyl-1-(2-methylpropyl)-N-(oxetan-3-yl)azetidin-3-amine;2-(2-methylpropyl)-5-oxa-2,8-diazaspiro[3.5]nonan-7-one;1-(2-methylpropyl)-4-(2,2,2-trifluoroethyl)piperazine;N,N,3-trimethyl-1-(2-methylpropyl)azetidine-3-carboxamide;trimethyl-[1-(2-methylpropyl)piperidin-4-yl]azanium?
The IUPAC name of N,N-dimethyl-1-(2-methylpropyl)azetidine-3-carboxamide;2,2-dimethyl-4-[1-(2-methylpropyl)azetidin-3-yl]morpholine;(3-hydroxyazetidin-1-yl)-[1-(2-methylpropyl)azetidin-3-yl]methanone;(3-hydroxypyrrolidin-1-yl)-[1-(2-methylpropyl)azetidin-3-yl]methanone;2-methyl-2-[methyl-[1-(2-methylpropyl)azetidin-3-yl]amino]propanamide;bis(7-methyl-2-(2-methylpropyl)-2,7-diazaspiro[3.5]nonan-6-one);N-methyl-1-(2-methylpropyl)-N-(oxetan-3-yl)azetidin-3-amine;2-(2-methylpropyl)-5-oxa-2,8-diazaspiro[3.5]nonan-7-one;1-(2-methylpropyl)-4-(2,2,2-trifluoroethyl)piperazine;N,N,3-trimethyl-1-(2-methylpropyl)azetidine-3-carboxamide;trimethyl-[1-(2-methylpropyl)piperidin-4-yl]azanium (CID 158227845) is N,N-dimethyl-1-(2-methylpropyl)azetidine-3-carboxamide;2,2-dimethyl-4-[1-(2-methylpropyl)azetidin-3-yl]morpholine;(3-hydroxyazetidin-1-yl)-[1-(2-methylpropyl)azetidin-3-yl]methanone;(3-hydroxypyrrolidin-1-yl)-[1-(2-methylpropyl)azetidin-3-yl]methanone;2-methyl-2-[methyl-[1-(2-methylpropyl)azetidin-3-yl]amino]propanamide;bis(7-methyl-2-(2-methylpropyl)-2,7-diazaspiro[3.5]nonan-6-one);N-methyl-1-(2-methylpropyl)-N-(oxetan-3-yl)azetidin-3-amine;2-(2-methylpropyl)-5-oxa-2,8-diazaspiro[3.5]nonan-7-one;1-(2-methylpropyl)-4-(2,2,2-trifluoroethyl)piperazine;N,N,3-trimethyl-1-(2-methylpropyl)azetidine-3-carboxamide;trimethyl-[1-(2-methylpropyl)piperidin-4-yl]azanium.
What is the SMILES notation for N,N-dimethyl-1-(2-methylpropyl)azetidine-3-carboxamide;2,2-dimethyl-4-[1-(2-methylpropyl)azetidin-3-yl]morpholine;(3-hydroxyazetidin-1-yl)-[1-(2-methylpropyl)azetidin-3-yl]methanone;(3-hydroxypyrrolidin-1-yl)-[1-(2-methylpropyl)azetidin-3-yl]methanone;2-methyl-2-[methyl-[1-(2-methylpropyl)azetidin-3-yl]amino]propanamide;bis(7-methyl-2-(2-methylpropyl)-2,7-diazaspiro[3.5]nonan-6-one);N-methyl-1-(2-methylpropyl)-N-(oxetan-3-yl)azetidin-3-amine;2-(2-methylpropyl)-5-oxa-2,8-diazaspiro[3.5]nonan-7-one;1-(2-methylpropyl)-4-(2,2,2-trifluoroethyl)piperazine;N,N,3-trimethyl-1-(2-methylpropyl)azetidine-3-carboxamide;trimethyl-[1-(2-methylpropyl)piperidin-4-yl]azanium?
The canonical SMILES for N,N-dimethyl-1-(2-methylpropyl)azetidine-3-carboxamide;2,2-dimethyl-4-[1-(2-methylpropyl)azetidin-3-yl]morpholine;(3-hydroxyazetidin-1-yl)-[1-(2-methylpropyl)azetidin-3-yl]methanone;(3-hydroxypyrrolidin-1-yl)-[1-(2-methylpropyl)azetidin-3-yl]methanone;2-methyl-2-[methyl-[1-(2-methylpropyl)azetidin-3-yl]amino]propanamide;bis(7-methyl-2-(2-methylpropyl)-2,7-diazaspiro[3.5]nonan-6-one);N-methyl-1-(2-methylpropyl)-N-(oxetan-3-yl)azetidin-3-amine;2-(2-methylpropyl)-5-oxa-2,8-diazaspiro[3.5]nonan-7-one;1-(2-methylpropyl)-4-(2,2,2-trifluoroethyl)piperazine;N,N,3-trimethyl-1-(2-methylpropyl)azetidine-3-carboxamide;trimethyl-[1-(2-methylpropyl)piperidin-4-yl]azanium is CC(C)CN1CC(C(=O)N(C)C)C1.CC(C)CN1CC(C(=O)N2CC(O)C2)C1.CC(C)CN1CC(C(=O)N2CCC(O)C2)C1.CC(C)CN1CC(C)(C(=O)N(C)C)C1.CC(C)CN1CC(N(C)C(C)(C)C(N)=O)C1.CC(C)CN1CC(N(C)C2COC2)C1.CC(C)CN1CC(N2CCOC(C)(C)C2)C1.CC(C)CN1CC2(CCN(C)C(=O)C2)C1.CC(C)CN1CC2(CCN(C)C(=O)C2)C1.CC(C)CN1CC2(CNC(=O)CO2)C1.CC(C)CN1CCC([N+](C)(C)C)CC1.CC(C)CN1CCN(CC(F)(F)F)CC1.
What is the InChIKey of N,N-dimethyl-1-(2-methylpropyl)azetidine-3-carboxamide;2,2-dimethyl-4-[1-(2-methylpropyl)azetidin-3-yl]morpholine;(3-hydroxyazetidin-1-yl)-[1-(2-methylpropyl)azetidin-3-yl]methanone;(3-hydroxypyrrolidin-1-yl)-[1-(2-methylpropyl)azetidin-3-yl]methanone;2-methyl-2-[methyl-[1-(2-methylpropyl)azetidin-3-yl]amino]propanamide;bis(7-methyl-2-(2-methylpropyl)-2,7-diazaspiro[3.5]nonan-6-one);N-methyl-1-(2-methylpropyl)-N-(oxetan-3-yl)azetidin-3-amine;2-(2-methylpropyl)-5-oxa-2,8-diazaspiro[3.5]nonan-7-one;1-(2-methylpropyl)-4-(2,2,2-trifluoroethyl)piperazine;N,N,3-trimethyl-1-(2-methylpropyl)azetidine-3-carboxamide;trimethyl-[1-(2-methylpropyl)piperidin-4-yl]azanium?
The InChIKey is YKYTVIMHKAFFLD-UHFFFAOYSA-N. The full InChI is InChI=1S/C13H26N2O.C12H25N3O.C12H22N2O2.2C12H22N2O.C12H27N2.C11H20N2O2.2C11H22N2O.C10H19F3N2.C10H18N2O2.C10H20N2O/c1-11(2)7-14-8-12(9-14)15-5-6-16-13(3,4)10-15;1-9(2)6-15-7-10(8-15)14(5)12(3,4)11(13)16;1-9(2)5-13-6-10(7-13)12(16)14-4-3-11(15)8-14;2*1-10(2)7-14-8-12(9-14)4-5-13(3)11(15)6-12;1-11(2)10-13-8-6-12(7-9-13)14(3,4)5;1-8(2)3-12-4-9(5-12)11(15)13-6-10(14)7-13;1-9(2)4-13-5-10(6-13)12(3)11-7-14-8-11;1-9(2)6-13-7-11(3,8-13)10(14)12(4)5;1-9(2)7-14-3-5-15(6-4-14)8-10(11,12)13;1-8(2)3-12-6-10(7-12)5-11-9(13)4-14-10;1-8(2)5-12-6-9(7-12)10(13)11(3)4/h11-12H,5-10H2,1-4H3;9-10H,6-8H2,1-5H3,(H2,13,16);9-11,15H,3-8H2,1-2H3;2*10H,4-9H2,1-3H3;11-12H,6-10H2,1-5H3;8-10,14H,3-7H2,1-2H3;9-11H,4-8H2,1-3H3;9H,6-8H2,1-5H3;9H,3-8H2,1-2H3;8H,3-7H2,1-2H3,(H,11,13);8-9H,5-7H2,1-4H3/q;;;;;+1;;;;;;.
What are the key properties of N,N-dimethyl-1-(2-methylpropyl)azetidine-3-carboxamide;2,2-dimethyl-4-[1-(2-methylpropyl)azetidin-3-yl]morpholine;(3-hydroxyazetidin-1-yl)-[1-(2-methylpropyl)azetidin-3-yl]methanone;(3-hydroxypyrrolidin-1-yl)-[1-(2-methylpropyl)azetidin-3-yl]methanone;2-methyl-2-[methyl-[1-(2-methylpropyl)azetidin-3-yl]amino]propanamide;bis(7-methyl-2-(2-methylpropyl)-2,7-diazaspiro[3.5]nonan-6-one);N-methyl-1-(2-methylpropyl)-N-(oxetan-3-yl)azetidin-3-amine;2-(2-methylpropyl)-5-oxa-2,8-diazaspiro[3.5]nonan-7-one;1-(2-methylpropyl)-4-(2,2,2-trifluoroethyl)piperazine;N,N,3-trimethyl-1-(2-methylpropyl)azetidine-3-carboxamide;trimethyl-[1-(2-methylpropyl)piperidin-4-yl]azanium?
N,N-dimethyl-1-(2-methylpropyl)azetidine-3-carboxamide;2,2-dimethyl-4-[1-(2-methylpropyl)azetidin-3-yl]morpholine;(3-hydroxyazetidin-1-yl)-[1-(2-methylpropyl)azetidin-3-yl]methanone;(3-hydroxypyrrolidin-1-yl)-[1-(2-methylpropyl)azetidin-3-yl]methanone;2-methyl-2-[methyl-[1-(2-methylpropyl)azetidin-3-yl]amino]propanamide;bis(7-methyl-2-(2-methylpropyl)-2,7-diazaspiro[3.5]nonan-6-one);N-methyl-1-(2-methylpropyl)-N-(oxetan-3-yl)azetidin-3-amine;2-(2-methylpropyl)-5-oxa-2,8-diazaspiro[3.5]nonan-7-one;1-(2-methylpropyl)-4-(2,2,2-trifluoroethyl)piperazine;N,N,3-trimethyl-1-(2-methylpropyl)azetidine-3-carboxamide;trimethyl-[1-(2-methylpropyl)piperidin-4-yl]azanium has a molecular weight of 2515.77 g/mol, XLogP of 10.15, 36 rotatable bonds, 4 hydrogen bond donors, and 29 hydrogen bond acceptors.
Where does this data come from?
All data for N,N-dimethyl-1-(2-methylpropyl)azetidine-3-carboxamide;2,2-dimethyl-4-[1-(2-methylpropyl)azetidin-3-yl]morpholine;(3-hydroxyazetidin-1-yl)-[1-(2-methylpropyl)azetidin-3-yl]methanone;(3-hydroxypyrrolidin-1-yl)-[1-(2-methylpropyl)azetidin-3-yl]methanone;2-methyl-2-[methyl-[1-(2-methylpropyl)azetidin-3-yl]amino]propanamide;bis(7-methyl-2-(2-methylpropyl)-2,7-diazaspiro[3.5]nonan-6-one);N-methyl-1-(2-methylpropyl)-N-(oxetan-3-yl)azetidin-3-amine;2-(2-methylpropyl)-5-oxa-2,8-diazaspiro[3.5]nonan-7-one;1-(2-methylpropyl)-4-(2,2,2-trifluoroethyl)piperazine;N,N,3-trimethyl-1-(2-methylpropyl)azetidine-3-carboxamide;trimethyl-[1-(2-methylpropyl)piperidin-4-yl]azanium is sourced from PubChem (CID 158227845), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).